Serotonergic neuronal sprouting as a potential mechanism of recovery in multiple sclerosis

International Journal of Neuroscience

Volumn 97, Issue 1-2, 1999, Pages 131-138

  Sandyk, Reuven ^a,b  

^a TOURO COLLEGE   (United States)

^b NONE   (United States)

Author keywords

Bulbospinal projection; EAE; Multiple sclerosis; Serotonin; Spinal cord; Sprouting

Indexed keywords

EID: 0033103814     PISSN: 00207454     EISSN: None     Source Type: Journal    
DOI: 10.3109/00207459908994307     Document Type: Article

References (18)

1. Andersen, O., Johansson, B. B. & Svennerholm, L. (1981) Monoamine metabolites in successive samples of spinal fluid: a comparison between healthy volunteers and patients with multiple sclerosis. Acta Neurologica Scandinavica, 63, 247-254.
2. Anderson, E. G. & Proudfit, H. K. (1981) The functional role of the bulbospinal serotonergic nervous system. In: Jacobs, B. L. and Gelperin, A. (Eds.), Serotonin: neurotransmission and behavior (pp. 307-338). London: MIT Press.
3. Azmita, E. C. & Whitaker-Azmitia, P. M. (1991) Awakening the sleeping giant: anatomy and plasticity of the brain serotonergic system. Journal of Clinical Psychiatry, 52, (suppl.) 4-16.
4. Baumgarten, H. G. & Lachenmayer, L. (1985) Anatomical features and physiological properties of central serotonin neurons. Pharmacopsyciatrie, 18, 180-187.
5. Bieger, D. & White, S. R. (1981) Anatomical evidence for bulbospinal monoamine axon damage in rats with experimental allergic encephalomyelitis. Neuroscience, 6, 1745-1752.
6. Bjorklund, A., Katzman, R., Stenevi, V. & West, K. A. (1971) Development and growth of axonal sprouts from noradrenaline and 5-hydroxytryptamine neurons in the rat spinal cord. Brain Research, 31, 21-33.
7. Carlsson, M. & Carlsson, A. (1988) In viovo evidence for a greater brain tryptophan hydroxylase capacity in female than male rats. Naunyn Schmiedebergs Archives of Pharmacology, 338, 345-349.
8. Claveria, L. E., Curzon, G., Harrison, M. J. G. & Kantamaneni, B. D. (1974) Amine metabolites in the cerebrospinal fluid of patients with disseminated sclerosis. Journal of Neurology Neurosurgery and Psychiatry, 37, 715-718.
9. Davidson, D., Pullar, I. A., Mawdsley, C., Kinloch, N. & Yates, C. M. (1977) Monoamine metabolites in cerebrospinal fluid in multiple sclerosis. Journal of Neurology Neurosurgery and Psychiatry, 40, 741-745.
10. Dong, Y. Q. (1992) The therapeutic effect of pulsed electric field on experimental spinal cord injury. Chung Hua Wai Ko Tsa Chih (China), 30, 180-183.
11. Feurer, C., Prentice, D. E. & Cammisuli, S. (1985) Chronic relapsing experimental allergic encephalomyelitis in the Lewis rat. Journal of Immunology, 10, 159-166.
12. Ffrench-constant, C. (1994) Pathogenesis of multiple sclerosis. Lancet, 343, 271-275.
13. Georgi, W. (1961) Multiple sclerose: pathologische-anatomische befunde multiple sclerose bei klinisch nicht diagnostizierten krankheiten. Schweizerischer Medizinische Wochenschrift, 91, 605-607.
14. Ghatak, N. R., Hirano, A., Lijtmaer, H. & Zimmerman, H. M. (1974) Asymptomatic demyelinated plaque in the spinal cord. Archives of Neurology, 30, 484-486.
15. Gilbert, J. J. & Sadler, M. (1983) Unsuspected multiple sclerosis. Archives of Neurology, 40, 533-536.
16. Haring, J. H. (1991) Reorganization of the area dentata serotonergc plexus after lesion of the median raphe nucleus. Journal of Comparative Neurology, 306, 576-584.
17. Hashimoto, T. & Fukuda, N. (1991) Contribution of serotonin neurons to the functional recovery after spinal cord injury in rats. Brain Research, 539, 263-270.
18. Hyyppa, M. T., Jolma, T., Riekkinen, P. & Rinne, U. K. (1975) Effects of L-tryptophan on central indoleamine metabolism and short-lasting neurologic disturbances in multiple sclerosis. Journal of Neural Transmission, 37, 297-304.